Flagship application · proposed
LBM Regulatory Intelligence: from botanical candidate to a defensible safety dossier.
Many botanicals used elsewhere in the world may be new dietary ingredients under U.S. law, depending on their identity, history, manufacturing and intended use. EUTECNIQ proposes to help companies work out which pathway applies, what evidence is missing, and which studies are worth running, then assemble a traceable dossier with qualified experts, laboratories and CROs.
DemonstrationThe screening rules below come from the statute, 21 CFR 190.6 and FDA guidance, as cited. No model is trained, no client exists and no notification has been prepared. This is not legal advice; FDA does not approve notifications.
01 · The workflow
Ten steps from candidate to dossier, each with an owner.
Models assist evidence synthesis, gap ranking and study planning. People decide: qualified laboratories and CROs produce the measurements, toxicologists and counsel review the conclusions.
Botanical identity and authenticity
Confirm the species, part and preparation against authenticated material; flag known adulterants.
Partner laboratory · model-assisted review
Ingredient history and eligibility
Pre-1994 marketing, food-supply history, chemical alteration and the drug exclusion, each answer cited.
EUTECNIQ · counsel confirms
Chemical and compositional characterization
Markers, fingerprints and batch consistency, with methods fit for the material.
Partner laboratory
Manufacturing-process definition
Flowchart, solvents, ratio and controls, so the notified ingredient is the one that will be made.
EUTECNIQ with the manufacturer
Contaminant and adulteration risk
Elements, pesticides, mycotoxins, microbes, residual solvents, ranked by source and process.
Model-assisted · partner laboratory
Toxicological evidence review
Systematic, traceable review of published toxicology and human data, with study quality appraised.
EUTECNIQ · toxicologist reviews
Exposure and intended use
Serving, frequency, duration and population against documented history: the exposure gap.
EUTECNIQ
Identification of data gaps
Every missing or partial piece of evidence, mapped to the guidance section that asks for it.
EUTECNIQ
Prioritization of studies
Cheapest decisive questions first; studies only where the gap and the literature require them.
EUTECNIQ · CROs run studies
Traceable dossier and expert review
Safety narrative and calculations with every source linked, reviewed by experts and counsel before filing.
EUTECNIQ · experts · counsel
02 · Demonstration
Screen a candidate: pathway, exposure gap, data gaps and a plan.
Load a hypothetical worked example or answer the questions yourself. The result updates as you go.
Rules: 21 U.S.C. 321(ff) and 350b(a), (d); 21 CFR 190.6; FDA final guidance, NDI notification procedures and timeframes (March 2024); FDA final guidance, NDI identity and safety information (October 2026), Sections VI, VII and Appendix A (Standard Safety Testing Table); FDA draft guidance (2016, revised October 2026) for when a notification is needed. Examples A, B and C are hypothetical and name no plant. Educational demonstration; legal conclusions belong with counsel.
03 · Inside the platform
Where the models would help, and where they cannot.
Evidence synthesis
Every claim linked to its source
Literature and records extracted into the knowledge graph with citations kept, so a reviewer can check each statement.
Exposure
The exposure gap, computed
Historical against proposed intake, including other sources, feeding the safety calculations FDA’s guidance describes.
Risk
Contaminant and adulteration ranking
Hazards ranked by species, origin and process, so testing goes where the risk is.
Planning
Studies ranked by what they decide
Avoidable studies identified with a documented rationale; required studies are never skipped.
04 · Who it is for
Suppliers, brands and manufacturers bringing a botanical to the U.S. market.
First
International botanical suppliers
Seeking U.S. market entry for an ingredient with use elsewhere, and a dossier they can own or reference.
First
U.S. brands and ingredient distributors
Evaluating a new botanical before they commit to a supplier or a launch.
First
Manufacturers
Needing standardization, formulation and evidence packages for a defined ingredient.
Later
Pharmaceutical and cosmetic developers
Needing ingredient intelligence under their own regulatory pathways.
The buyer pays for a decision and an evidence-backed development path, not another stand-alone test report. Engagements would start as fixed-scope feasibility work. None is available yet.
Health information notice. These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease, and nothing here is medical advice.
Read the full notice
The information is for general education only. It does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed. Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.